CD44 and neoplasm: In addition, the resistance and recurrence upon treatment with chemotherapy were strongly associated with the enrichment of CD44 and ALDH1A3 CSC markers in the FOLFOX-treated tumor organoids (tumoroids) derived from Apc1638N mouse gastric tumors.